Loss of Neutral Ceramidase Protects Cells from Nutrient- and Energy -deprivation-induced Cell Death
Overview
Authors
Affiliations
Sphingolipids are a family of lipids that regulate the cell cycle, differentiation and cell death. Sphingolipids are known to play a role in the induction of apoptosis, but a role for these lipids in necroptosis is largely unknown. Necroptosis is a programmed form of cell death that, unlike apoptosis, does not require ATP. Necroptosis can be induced under a variety of conditions, including nutrient deprivation and plays a major role in ischaemia/reperfusion injury to organs. Sphingolipids play a role in ischaemia/reperfusion injury in several organs. Thus, we hypothesized that sphingolipids mediate nutrient-deprivation-induced necroptosis. To address this, we utilized mouse embryonic fibroblast (MEFs) treated with 2-deoxyglucose (2DG) and antimycin A (AA) to inhibit glycolysis and mitochondrial electron transport. 2DG/AA treatment of MEFs induced necroptosis as it was receptor- interacting protein (RIP)-1/3 kinase-dependent and caspase-independent. Ceramides, sphingosine (Sph) and sphingosine 1-phosphate (S1P) were increased following 2DG/AA treatment. Cells lacking neutral ceramidase (nCDase(-/-)) were protected from 2DG/AA. Although nCDase(-/-) cells generated ceramides following 2DG/AA treatment, they did not generate Sph or S1P. This protection was stimulus-independent as nCDase(-/-) cells were also protected from endoplasmic reticulum (ER) stressors [tunicamycin (TN) or thapsigargin (TG)]. nCDase(-/-) MEFs had higher autophagic flux and mitophagy than wild-type (WT) MEFs and inhibition of autophagy sensitized them to necroptosis. These data indicate that loss of nCDase protects cells from nutrient- deprivation-induced necroptosis via autophagy, and clearance of damaged mitochondria. Results suggest that nCDase is a mediator of necroptosis and might be a novel therapeutic target for protection from ischaemic injury.
Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia.
Zou W, Li M, Wan S, Ma J, Lian L, Luo G Adv Sci (Weinh). 2024; 11(38):e2405963.
PMID: 39120042 PMC: 11481256. DOI: 10.1002/advs.202405963.
Sphingolipid metabolism and regulated cell death in malignant melanoma.
Yan K, Zhang W, Song H, Xu X Apoptosis. 2024; 29(11-12):1860-1878.
PMID: 39068623 DOI: 10.1007/s10495-024-02002-y.
Surendran S, Krishnan R, Ramani P, Ramalingam K, Jayaraman S Cureus. 2023; 15(7):e42308.
PMID: 37614280 PMC: 10442516. DOI: 10.7759/cureus.42308.
Endoplasmic reticulum stress and mitochondrial dysfunction during aging: Role of sphingolipids.
Chen Q, Kovilakath A, Allegood J, Thompson J, Hu Y, Cowart L Biochim Biophys Acta Mol Cell Biol Lipids. 2023; 1868(10):159366.
PMID: 37473835 PMC: 11154090. DOI: 10.1016/j.bbalip.2023.159366.
Wohner M, Pinter T, Bonelt P, Hagelkruys A, Kostanova-Poliakova D, Stadlmann J Front Immunol. 2023; 13:859598.
PMID: 36618345 PMC: 9811352. DOI: 10.3389/fimmu.2022.859598.